MedReleaf Corp. (TSX: LEAF) and BioPharma Services Inc. today announced they have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products. Under the agreement BioPharma will become an extension of MedReleaf's clinic development team.
Articles
The Green Organic Dutchman to Exclusively License Fast-Acting Stillwater Foods’ RIPPLE SC (Soluble Cannabinoids) and Other Proprietary Beverage and Food Technologies
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is pleased to announce that the Company has entered into an exclusive agreement with Stillwater Brands to license RIPPLE SC (Soluble Cannabinoids) ingredient technology, and other proprietary beverage and food technologies and formulations related to cannabinoid-infused consumer packaged goods including micro-dose and full-dose tea sticks within Canada and certain international jurisdictions outside of the USA.
Dr. Mark Ware Joins Canopy Growth Corporation as Chief Medical Officer
Canopy Growth Corporation (TSX: WEED, NYSE: CGC) is pleased to announce that Dr. Mark Ware, a leading researcher in the cannabis field for decades, will join the senior leadership team at Canopy Growth as the Company's Chief Medical Officer commencing July 1st, 2018.
Aurora Cannabis Signs Agreement with Heinrich Klenk GmbH & Co. KG
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company, through its wholly owned subsidiary Pedanios GmbH, has signed a collaboration agreement with Heinrich Klenk GmbH & Co. KG, one of Europe's largest medicinal plant companies.
CannTrust to Launch Three New Recreational Brands: Liiv™, Synr.g™ and Xscape™
CannTrust® Holdings Inc. (TSX: TRST), one of Canada's leading licensed producers, manufacturers and distributors of cannabis, today announced that it will be entering the recreational cannabis market together with the launch of new Brands.
Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary's Medicinals Cannabis Products to Massachusetts
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) today announced the expansion of the Company's partnership with Colorado-based MM Technology Holdings, LLC to be the exclusive provider of the award-winning line of Mary's Medicinals® cannabis products in Massachusetts.
Aurora Cannabis Retains KCSA Strategic Communications to Enhance U.S. investor and Media Outreach
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced it has appointed retained KCSA Strategic Communications, a leading New York-based communications firm, to support the Company's strategic communications and investor relations efforts in the United States.
Pharmacists urge Senate to include more support for patients as they consider Bill C-45 to legalize cannabis
Pharmacists are asking the Senate to include more support for patients who use medical cannabis by ensuring that there is a clear differentiation between the recreational and medical cannabis streams, with incentives for patients to remain in the medical cannabis stream.
Hydropothecary launches a new brand for recreational cannabis: Introducing HEXO
The Hydropothecary Corporation (TSXV:THCX) today introduced HEXO, a new brand for the recreational adult-use cannabis market. The launch of this brand is taking place at the Lift Cannabis Expo in Toronto, Ontario. The company announces application to graduate to the Toronto Stock Exchange
Newstrike Resources Ltd. Announces $40 Million Bought Deal Public Offering
Newstrike Resources Ltd. (TSXV:HIP) is pleased to announce that it has entered into an agreement with a syndicate of investment dealers co-led by Cormark Securities Inc. and INFOR Financial Inc. pursuant to which the Underwriters have agreed to purchase 53,350,000 units from the treasury of the Company, at a price of $0.75 per Unit and offer them to the public by way of short form prospectus for total gross proceeds of approximately $40 million.
Canopy Growth Announces Inaugural Trading Date on the New York Stock Exchange
Canopy Growth Corporation (TSX: WEED) is pleased to announce that it expects its common shares will begin trading under the ticker symbol "CGC" on the New York Stock Exchange, May 24, 2018.
Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.
Investment in Hyasynth Biologicals Inc. would advance Organigram's interest in next generation cannabinoids
ABcann Launches Beacon Medical
ABcann Global Corporation (TSX-V:ABCN) is pleased to announce the launch of Beacon Medical, its new medical cannabis brand.
Newstrike to Make Strategic Investment in Retail Distribution
Newstrike Resources Ltd. (TSXV:HIP) is pleased to announce that it has entered into an investment agreement with Inner Spirit Holdings Ltd. dated May 18, 2018, pursuant to which both Newstrike and Inner Spirit will acquire equity interests in each other and enter into a companion strategic alliance agreement for the retail distribution of Up Cannabis products and the creation and operation of Up Cannabis-branded customer lounges or “Experiential Hubs” in each of Inner Spirit’s stores.
Empower appoints McDonough to board
EMPOWER CLINICS ADDS BRAND AND MARKETING PIONEER PETER MCDONOUGH TO BOARD OF DIRECTORS
